THE INVESTOR

메뉴열기
December 13, 2018

Feelux’s subsidiary to acquire US bio firm at W16.1b

PUBLISHED : June 12, 2018 - 14:33

UPDATED : June 12, 2018 - 14:33

  • 본문폰트 작게
  • 본문폰트 크게
  • 페이스북
  • 트위터
  • sms

[DISCLOSURE] Feelux (033180) announced on June 12 that its subsidiary CAR-TCellKor has decided to take over 100 percent stake in US bio company Liminatus Pharma at 16.1 billion won (US$14.98 million). 

This amounts to 8.39 percent of its equity capital. 

By Hwang You-mee (glamazon@heraldcorp.com)

  • 페이스북
  • 트위터
  • sms
최상단으로
Herald Corporation|CEO : Kwon Chung Won
Chief Privacy Officer & Juvenile Protection Manager : Shin Chang Hoon
Company Registration No. 104-81-06004
Mail-Order Business Registration 2016 - Seoul Yongsan - 00590
Huam-ro 4-gil 10, Yongsan-gu, Seoul, Korea
T : +82-2-727-0615|Business info
COPYRIGHT HERALD CORPORATION. ALL RIGHTS RESERVED.